APA (7th ed.) Citation

Dummer, R., Hauschild, A., Santinami, M., Atkinson, V., Mandalà, M., Kirkwood, J. M., . . . Long, G. V. (2020). Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma. New England Journal of Medicine, 383(12), 1139. https://doi.org/10.1056/NEJMoa2005493

Chicago Style (17th ed.) Citation

Dummer, R., et al. "Five-Year Analysis of Adjuvant Dabrafenib Plus Trametinib in Stage III Melanoma." New England Journal of Medicine 383, no. 12 (2020): 1139. https://doi.org/10.1056/NEJMoa2005493.

MLA (9th ed.) Citation

Dummer, R., et al. "Five-Year Analysis of Adjuvant Dabrafenib Plus Trametinib in Stage III Melanoma." New England Journal of Medicine, vol. 383, no. 12, 2020, p. 1139, https://doi.org/10.1056/NEJMoa2005493.